20080902
 Medical Journal Raises Concern About Vytorin   By Alicia Mundy and Jared Favole, The Wall Street Journal,  Sep 3, 2008  Later Tuesday, a powerful congressional committee that has been investigating Vytorin's safety and marketing sent a letter to Merck & Co. and Schering-Plough Corp., who sell the drug in a joint venture, asking for extensive details about the Oxford review that dismissed links between Vytorin and cancer deaths.   
